Revive Therapeutics Ltd. Appoints Arun Sanyal as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
August 22, 2017 at 09:37 am
Revive Therapeutics Ltd. ("Revive" or the "company") announced that Dr. Arun Sanyal, M.D., will join the company as a Scientific Advisor for cannabinoid-based therapeutics targeting liver diseases. Arun Sanyal, MD, has developed, mediated and encouraged global liver research as a physician-scientist for 25 years. Currently, Dr. Sanyal is Professor of Gastroenterology, Hepatology and Nutrition at the Virginia Commonwealth University (VCU) School of Medicine.